Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial.
Saved in:
| Title: | Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18-64 Years: Results and Experience From a Randomized, Double-Blind Trial. |
|---|---|
| Authors: | Grant L; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitaker JA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Yoon SK; Rocky Mountain Center for Occupational and Environmental Health, Division of Occupational and Environmental Health, University of Utah Health, Salt Lake City, Utah, USA., Lutrick K; Family and Community Medicine, College of Medicine-Tucson, University of Arizona Health Sciences, Tucson, Arizona, USA., Bhargava S; Center for Asian Health Equity, Asian Health Coalition, University of Chicago, Chicago, Illinois, USA., Brown CP; Institute of Public Health, Florida A&M University, Tallahassee, Florida, USA., Zaragoza E; CVS Health Clinical Trials Services, Lakewood, Colorado, USA., Fink RV; Westat Inc, Rockville, Maryland, USA., Meece J; Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA., Wielgosz K; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., El Sahly H; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Hegmann KT; Rocky Mountain Center for Occupational and Environmental Health, Division of Occupational and Environmental Health, University of Utah Health, Salt Lake City, Utah, USA., Lowe AA; Advanced Nursing Practice and Science Division, College of Nursing, University of Arizona, Tucson, Arizona, USA., Southworth A; Center for Asian Health Equity, Asian Health Coalition, University of Chicago, Chicago, Illinois, USA., Tatum T; Institute of Public Health, Florida A&M University, Tallahassee, Florida, USA., Ball SW; Westat Inc, Rockville, Maryland, USA., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Thiese MS; Rocky Mountain Center for Occupational and Environmental Health, Division of Occupational and Environmental Health, University of Utah Health, Salt Lake City, Utah, USA., Battan-Wraith S; Westat Inc, Rockville, Maryland, USA., Barnes J; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Phillips AL; Rocky Mountain Center for Occupational and Environmental Health, Division of Occupational and Environmental Health, University of Utah Health, Salt Lake City, Utah, USA., Fry AM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dawood FS; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. |
| Corporate Authors: | Randomized Assessment of Influenza Vaccine Efficacy Network (RAIVEN) |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2024 Sep 26; Vol. 11 (10), pp. ofae559. Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024). |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
